Genetic Test Can Identify Triple Negative Breast Cancer Treatment Responders

A test including 53 genes can predict who will respond and who will not respond to triple negative breast cancer immunotherapy.

Mutational signatures of triple-negative breast cancer (TNBC). (A

Understanding the 3D Shape of the Genome Reveals Future Cancer

Treatment of Aggressive Cancer Improved by Sequential Combination

Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer

CRISPR/Cas9 based genome editing for targeted transcriptional

HER2 Positive and Negative Breast Cancers: Aggressiveness

Mount Sinai Team Identify 4,729 Gene Clusters That Influence

Current Oncology, Free Full-Text

What Is Triple-Negative Breast Cancer?

Molecular subtypes and precision treatment of triple-negative

Caris, Hummingbird Bio Collaborate on Anti-HER3 Therapy

Broadening Access to Biomarker Testing to Accelerate Precision

Ultra-Sensitive, Multiplexed Molecular Detection for Biomarker

Renal cell carcinoma Archives - Inside Precision Medicine